[ Price : $8.95]
Hundreds of U.S. biomedical innovators and investors urge the Senate to help restore critical FDA staff that were recently laid of...[ Price : $8.95]
FDA accepts for review an Outlook Therapeutics BLA resubmission for ONS-5010 (bevacizumab-vikg), an investigational ophthalmic for...[ Price : $8.95]
The Government Accountability Office says HHS should have some mechanism in place to coordinate the activities of various HHS agen...[ Price : $8.95]
FDA approves updated labeling for Idorsias blood pressure drug Tryvio after approving the elimination of a REMS requirement.[ Price : $8.95]
Members of Congress from Maryland, led by Rep. Jamie Raskin, ask to meet with FDA commissioner Martin Makary to discuss their conc...[ Price : $8.95]
Former FDA commissioner David Kessler tells a House hearing that recent FDA staff cuts will adversely affect the U.S.s public heal...[ Price : $8.95]
The Minneapolis Star Tribune says medical device companies are concerned that FDA layoffs have resulted in fewer device approvals ...